{"id":"https://openalex.org/W4403832142","doi":"https://doi.org/10.1681/asn.2024100bxw99","title":"Dapagliflozin Ameliorates High-Fat, Diet-Induced, Megalin-Mediated Autolysosomal Disorders in Mouse Proximal Tubules","display_name":"Dapagliflozin Ameliorates High-Fat, Diet-Induced, Megalin-Mediated Autolysosomal Disorders in Mouse Proximal Tubules","publication_year":2024,"publication_date":"2024-10-01","ids":{"openalex":"https://openalex.org/W4403832142","doi":"https://doi.org/10.1681/asn.2024100bxw99"},"language":"en","primary_location":{"id":"doi:10.1681/asn.2024100bxw99","doi":"https://doi.org/10.1681/asn.2024100bxw99","is_oa":false,"landing_page_url":"https://doi.org/10.1681/asn.2024100bxw99","pdf_url":null,"source":{"id":"https://openalex.org/S115693375","display_name":"Journal of the American Society of Nephrology","issn_l":"1046-6673","issn":["1046-6673","1533-3450"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310315620","host_organization_name":"American Society of Nephrology","host_organization_lineage":["https://openalex.org/P4310315620"],"host_organization_lineage_names":["American Society of Nephrology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the American Society of Nephrology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Kazuya Takemoto","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I71395657","display_name":"Niigata University","ror":"https://ror.org/04ww21r56","country_code":"JP","type":"education","lineage":["https://openalex.org/I71395657"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kazuya Takemoto","raw_affiliation_strings":["Niigata University, Niigata City, Niigata, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Niigata University, Niigata City, Niigata, Japan","institution_ids":["https://openalex.org/I71395657"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002881989","display_name":"Michihiro Hosojima","orcid":"https://orcid.org/0000-0002-2750-735X","observed_orcids":["https://orcid.org/0000-0002-2750-735X"]},"institutions":[{"id":"https://openalex.org/I71395657","display_name":"Niigata University","ror":"https://ror.org/04ww21r56","country_code":"JP","type":"education","lineage":["https://openalex.org/I71395657"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Michihiro Hosojima","raw_affiliation_strings":["Niigata University, Niigata City, Niigata, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Niigata University, Niigata City, Niigata, Japan","institution_ids":["https://openalex.org/I71395657"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034883318","display_name":"Hideyuki Kabasawa","orcid":"https://orcid.org/0009-0005-2159-7971","observed_orcids":["https://orcid.org/0009-0005-2159-7971"]},"institutions":[{"id":"https://openalex.org/I71395657","display_name":"Niigata University","ror":"https://ror.org/04ww21r56","country_code":"JP","type":"education","lineage":["https://openalex.org/I71395657"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hideyuki Kabasawa","raw_affiliation_strings":["Niigata University, Niigata City, Niigata, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Niigata University, Niigata City, Niigata, Japan","institution_ids":["https://openalex.org/I71395657"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042533774","display_name":"Ichiei Narita","orcid":"https://orcid.org/0000-0001-7692-3096","observed_orcids":["https://orcid.org/0000-0001-7692-3096"]},"institutions":[{"id":"https://openalex.org/I71395657","display_name":"Niigata University","ror":"https://ror.org/04ww21r56","country_code":"JP","type":"education","lineage":["https://openalex.org/I71395657"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Ichiei Narita","raw_affiliation_strings":["Niigata University, Niigata City, Niigata, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Niigata University, Niigata City, Niigata, Japan","institution_ids":["https://openalex.org/I71395657"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5074733950","display_name":"Akihiko Saito","orcid":"https://orcid.org/0000-0002-1301-1126","observed_orcids":["https://orcid.org/0000-0002-1301-1126"]},"institutions":[{"id":"https://openalex.org/I71395657","display_name":"Niigata University","ror":"https://ror.org/04ww21r56","country_code":"JP","type":"education","lineage":["https://openalex.org/I71395657"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Akihiko Saito","raw_affiliation_strings":["Niigata University, Niigata City, Niigata, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Niigata University, Niigata City, Niigata, Japan","institution_ids":["https://openalex.org/I71395657"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I71395657"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.24832865,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"35","issue":"10S","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10587","display_name":"Autophagy in Disease and Therapy","score":0.5479000210762024,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10587","display_name":"Autophagy in Disease and Therapy","score":0.5479000210762024,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10408","display_name":"Chronic Kidney Disease and Diabetes","score":0.2912999987602234,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11029","display_name":"Renal Diseases and Glomerulopathies","score":0.046799998730421066,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/megalin","display_name":"megalin","score":0.9419999718666077},{"id":"https://openalex.org/keywords/sglt2-inhibitors","display_name":"SGLT2 inhibitors","score":0.7459999918937683},{"id":"https://openalex.org/keywords/high-fat-diet","display_name":"high-fat diet","score":0.8830000162124634},{"id":"https://openalex.org/keywords/proximal-tubule","display_name":"proximal tubule","score":0.7379999756813049},{"id":"https://openalex.org/keywords/receptor-mediated-endocytosis","display_name":"receptor-mediated endocytosis","score":0.8429999947547913},{"id":"https://openalex.org/keywords/fluid-phase-endocytosis","display_name":"fluid-phase endocytosis","score":0.9990000128746033},{"id":"https://openalex.org/keywords/lipotoxicity","display_name":"lipotoxicity","score":0.6539999842643738},{"id":"https://openalex.org/keywords/alpha-1-microglobulin","display_name":"alpha1-microglobulin","score":0.7720000147819519},{"id":"https://openalex.org/keywords/diabetic-nephropathy","display_name":"diabetic nephropathy","score":0.5440000295639038},{"id":"https://openalex.org/keywords/endolysosomal-dysfunction","display_name":"endolysosomal dysfunction","score":0.4580000042915344}],"concepts":[{"id":"https://openalex.org/C2777422806","wikidata":"https://www.wikidata.org/wiki/Q409898","display_name":"Dapagliflozin","level":4,"score":0.7563296556472778},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5367478132247925},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.5184563994407654},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4009997248649597},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.39910632371902466},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3241865038871765},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.2737085819244385},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.14595180749893188}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1681/asn.2024100bxw99","doi":"https://doi.org/10.1681/asn.2024100bxw99","is_oa":false,"landing_page_url":"https://doi.org/10.1681/asn.2024100bxw99","pdf_url":null,"source":{"id":"https://openalex.org/S115693375","display_name":"Journal of the American Society of Nephrology","issn_l":"1046-6673","issn":["1046-6673","1533-3450"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310315620","host_organization_name":"American Society of Nephrology","host_organization_lineage":["https://openalex.org/P4310315620"],"host_organization_lineage_names":["American Society of Nephrology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the American Society of Nephrology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/2","display_name":"Zero hunger","score":0.8500000238418579}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2899084033","https://openalex.org/W2748952813","https://openalex.org/W4391375266","https://openalex.org/W1979139803","https://openalex.org/W1966504330","https://openalex.org/W2037631372","https://openalex.org/W2132898409","https://openalex.org/W2030889776","https://openalex.org/W4249176446","https://openalex.org/W1966775726"],"abstract_inverted_index":{"Background:":[0],"Megalin":[1],"is":[2,60,80],"a":[3,35,158],"multi-ligand":[4],"endocytic":[5,181,193],"receptor":[6],"located":[7],"in":[8,32,46,67,77,107,163,214,249,276,292,302],"the":[9,61,97,151,187,240,269,280,287],"apical":[10],"membrane":[11],"of":[12,25,50,99,109,128,190,195,208,271,282,289,304],"proximal":[13],"tubules":[14],"(PTs).":[15],"Our":[16],"prior":[17],"study":[18],"(JASN":[19],"2016)":[20],"elucidated":[21],"that":[22],"megalin-mediated":[23,298],"endocytosis":[24,58,74],"glomerular-filtered":[26],"lipotoxic":[27],"substances":[28],"drives":[29],"tubulo-glomerular":[30],"alterations":[31],"mice":[33,111,120,221,227,285],"fed":[34,122],"high-fat":[36],"diet":[37],"(HFD).":[38],"In":[39,265],"this":[40],"model,":[41],"pathological":[42],"vacuolation":[43],"appears":[44],"particularly":[45,301],"segment":[47],"2":[48],"(S2)":[49],"PTs":[51,108,164,277,305],"due":[52,85],"to":[53,82,86,95,284],"megalin-dependent":[54],"autolysosomal":[55,105,299],"disorders.":[56],"Receptor-mediated":[57],"(RME)":[59],"primary":[62],"pathway":[63],"for":[64,135,160,232],"substance":[65],"uptake":[66,270,288],"S1":[68],"(greater":[69],"than":[70],"S2),":[71],"while":[72],"fluid-phase":[73],"(FPE)":[75],"prevails":[76],"S2,":[78],"which":[79],"vulnerable":[81],"metabolic":[83],"overload":[84,162],"its":[87,113],"less":[88],"advanced":[89],"endolysosomal":[90],"systems.":[91],"This":[92],"investigation":[93],"aims":[94],"explore":[96],"impact":[98],"dapagliflozin,":[100],"an":[101,123,192],"SGLT2":[102],"inhibitor,":[103],"on":[104,202,313],"disorders":[106,300],"HFD-fed":[110,250],"and":[112,145,178,198,211,222,225,245,274,310],"underlying":[114],"mechanism.":[115],"Methods:":[116],"Nine-week-old":[117],"male":[118,216],"C57BL/6J":[119,226],"were":[121,200],"HFD":[124],"with":[125,262],"oral":[126],"administration":[127,237,281],"dapagliflozin":[129,229,263,283],"(1mg/kg":[130],"body":[131],"weight/day)":[132],"or":[133,230],"vehicle":[134,231],"28":[136],"days":[137],"(n=10":[138],"each).":[139],"Kidney":[140],"sections":[141,204],"underwent":[142],"PAS":[143],"staining,":[144],"Image-Pro":[146],"Plus":[147],"ver.":[148],"7.0":[149],"evaluated":[150],"vacuolar":[152,241],"area/cortical":[153,242],"tubular":[154,243],"area.":[155],"Urinary":[156],"C-megalin,":[157],"marker":[159],"lysosomal":[161],"(Diabetes":[165],"2017),":[166],"was":[167,173,183],"also":[168],"measured.":[169],"Renal":[170],"megalin":[171,219,254,266],"expression":[172,255],"gauged":[174],"via":[175],"immunoblotting,":[176],"qPCR,":[177],"immunohistochemistry.":[179],"Megalin's":[180],"function":[182],"assessed":[184],"by":[185,306],"measuring":[186],"urinary":[188,246,258],"excretion":[189,248,260],"\u03b11-microglobulin,":[191],"ligand":[194],"megalin.":[196,314],"RME":[197,309],"FPE":[199,311],"scrutinized":[201],"kidney":[203],"post":[205],"intravenous":[206],"injection":[207],"fluorescent":[209,272],"lysozyme":[210,273],"dextran,":[212],"respectively,":[213],"9-week-old":[215],"kidney-specific":[217],"conditional":[218],"KO":[220,267],"littermate":[223],"controls,":[224],"receiving":[228],"5":[233],"days.":[234],"Results:":[235],"Dapagliflozin":[236,295],"significantly":[238],"reduced":[239],"area":[244],"C-megalin":[247],"mice.":[251],"While":[252],"renal":[253],"remained":[256],"unaltered,":[257],"\u03b11-microglobulin":[259],"increased":[261],"administration.":[264],"mice,":[268],"dextran":[275],"decreased.":[278],"Similarly,":[279],"diminished":[286],"both":[290,308],"tracers":[291],"PTs.":[293],"Conclusion:":[294],"ameliorates":[296],"HFD-induced,":[297],"S2":[303],"suppressing":[307],"dependent":[312],"Funding:":[315],"Commercial":[316],"Support":[317,323],"-":[318],"Denka":[319],"Company":[320],"Limited,":[321],"Government":[322],"\u2013":[324],"Non-U.S.":[325]},"counts_by_year":[],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2025-10-10T00:00:00"}